Sequential treatment of central retinal vein occlusion with intravitreal tissue plasminogen activator and intravitreal triamcinolone [8]

British Journal of Ophthalmology

Volumn 88, Issue 8, 2004, Pages 1100-1101

  L, J M ^a   K, J J ^a,b   Cheung, M C ^a   Lahey, J M ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Ophthalmology   (United States)

^c KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR; TRIAMCINOLONE;

ADULT; CASE REPORT; CENTRAL RETINA VEIN OCCLUSION; FLUORESCENCE ANGIOGRAPHY; HUMAN; HYPERTENSION; LETTER; OBESITY; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL RESOLUTION; PRIORITY JOURNAL; RETINA MACULA EDEMA; STATISTICAL SIGNIFICANCE; VISION; VISUAL DISORDER; VISUAL IMPAIRMENT;

ANTI-INFLAMMATORY AGENTS; DRUG THERAPY, COMBINATION; FLUORESCEIN ANGIOGRAPHY; HUMANS; INJECTIONS; MIDDLE AGED; PLASMINOGEN ACTIVATORS; RETINAL VEIN OCCLUSION; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; TRIAMCINOLONE;

EID: 3543133131     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2004.043406     Document Type: Letter

References (10)

1. Opremcak EM, Bruce RA, Lomeo MD, et al. Radial optic neurotomy for central retinal vein occlusion: a retrospective pilot study of 11 consecutive cases. Retina 2001;21:408-15.
2. Weiss JN, Byone LA. Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion. Ophthalmology 2001;108:2249-57.
3. Lahey JM, Fong DS, Kearney J. Intravitreal tissue plasminogen activator for acute central retinal vein occlusion. Ophthalmic Surg Lasers 1999;30:427-34.
4. Weizer JS, Fekrat S. Intravitreal tissue plasminogen activator for the treatment of central retinal vein occlusion. Ophthalmic Surg Lasers Imaging 2003;34:350-2.
5. Glacet-Bernard A, Kuhn D, Vine AK, et al. Treatment of recent onset central retinal vein occlusion with intravitreal tissue plasminogen activator: a pilot study. Br J Ophthalmol 2000;84:609-13.
6. Ghazi NG, Noureddine B, Haddad RS, et al. Intravitreal tissue plasminogen activator in the management of central retinal vein occlusion. Retina 2003;23:780-4.
7. Elman MJ, Raden RZ, Carrigan A. Intravitreal injection of tissue plasminogen activator for central retinal vein occlusion. Trans Am Ophthalmol Soc. 2001;99: 219-21; discussion 222-3).
8. Kamei M, Misono K, Lewis H. A study of the ability of tissue plasminogen activator to diffuse into the subretinal space after intravitreal injection in rabbits. Am J Ophthalmol 1999;128:739-46.
9. Mahmoud TH, Peng Y-W, Proia A, et al. Intravitreal tissue plasminogen activator penetrotes the retinal veins in a porcine model of vascular occlusion. Invest Ophthalmol Vis Sci. 2002;43: E-abstract 3533, Presented at ARVO, 2002.
10. Greenberg PB, Martidis A, Rogers AH, et al. Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Br J Ophthalmol 2002;86:247-8.